These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2460613)

  • 41. Quantitative estimation of renal clearance of N-acetylprocainamide in rats with various experimental acute renal failure.
    He YL; Kitada N; Yasuhara M; Hori R
    Eur J Pharm Sci; 2001 Jun; 13(3):303-8. PubMed ID: 11384853
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kinetics of procainamide and N-acetylprocainamide in renal failure.
    Gibson TP; Atkinson AJ; Matusik E; Nelson LD; Briggs WA
    Kidney Int; 1977 Dec; 12(6):422-9. PubMed ID: 609192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The quantitative disposition of procainamide and N-acetylprocainamide in the rat.
    Schneck DW; Grove K; Dewitt FO; Shiroff RA; Hayes AH
    J Pharmacol Exp Ther; 1978 Jan; 204(1):219-25. PubMed ID: 619132
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Combined pharmacokinetic and pharmacodynamic model analysis for procainamide and its metabolite].
    Liu XQ; Huang SK
    Zhongguo Yao Li Xue Bao; 1991 Jan; 12(1):7-11. PubMed ID: 1719744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of age, gender, and race on steady state procainamide pharmacokinetics after administration of procanbid sustained-release tablets.
    Koup JR; Abel RB; Smithers JA; Eldon MA; de Vries TM
    Ther Drug Monit; 1998 Feb; 20(1):73-7. PubMed ID: 9485559
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of N-acetylprocainamide.
    Atkinson AJ; Ruo TI
    Angiology; 1986 Dec; 37(12 Pt 2):959-67. PubMed ID: 2433970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma concentrations of desethyl N-acetylprocainamide in patients treated with procainamide and N-acetylprocainamide.
    Ruo TI; Thenot JP; Stec GP; Atkinson AJ
    Ther Drug Monit; 1981; 3(3):231-7. PubMed ID: 6172888
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dose-dependency in the exsorption of theophylline and the intestinal dialysis of theophylline by oral activated charcoal in rats.
    Arimori K; Nakano M
    J Pharm Pharmacol; 1988 Feb; 40(2):101-5. PubMed ID: 2897439
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kinetics of N-acetylprocainamide deacetylation.
    Stec GP; Ruo TI; Thenot JP; Atkinson AJ; Morita Y; Lertora JJ
    Clin Pharmacol Ther; 1980 Nov; 28(5):659-66. PubMed ID: 6160014
    [TBL] [Abstract][Full Text] [Related]  

  • 50. More-sensitive enzyme-multiplied immunoassay technique for procainamide and N-acetylprocainamide in plasma, serum, and urine.
    Henry PR; Dhruv RA
    Clin Chem; 1988 May; 34(5):957-60. PubMed ID: 2453309
    [TBL] [Abstract][Full Text] [Related]  

  • 51. N-Acetylprocainamide levels in patients with end-stage renal failure.
    Gibson TP; Matusik EJ; Briggs WA
    Clin Pharmacol Ther; 1976 Feb; 19(2):206-12. PubMed ID: 1261157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Torsades de pointes due to n-acetylprocainamide.
    Stevenson WG; Weiss J
    Pacing Clin Electrophysiol; 1985 Jul; 8(4):528-31. PubMed ID: 2410877
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pharmacokinetics and pharmacodynamics of procainamide in horses after intravenous administration.
    Ellis EJ; Ravis WR; Malloy M; Duran SH; Smyth BG
    J Vet Pharmacol Ther; 1994 Aug; 17(4):265-70. PubMed ID: 7525982
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of procainamide and N-acetylprocainamide on atrial flutter: studies in vivo and in vitro.
    Wu KM; Hoffman BF
    Circulation; 1987 Dec; 76(6):1397-408. PubMed ID: 2445503
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of computer-assisted radiotelemetry in the pharmacokinetic and pharmacodynamic modeling of procainamide and N-acetylprocainamide.
    Kharidia J; Eddington ND
    J Pharm Sci; 1996 Jun; 85(6):595-9. PubMed ID: 8773955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transport of theophylline from blood to the intestinal lumen following i.v. administration to rats.
    Arimori K; Nakano M
    J Pharmacobiodyn; 1985 Apr; 8(4):324-7. PubMed ID: 4032222
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of amiodarone on the disposition of procainamide in the rat.
    Liu LL; Knowlton PW; Svensson CK
    J Pharm Sci; 1988 Aug; 77(8):662-5. PubMed ID: 3210153
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Procainamide pharmacokinetics in beagles: urinary pH dependency and comparison with n-acetylprocainamide.
    Baer DT; Barkus JC
    Res Commun Chem Pathol Pharmacol; 1977 Jun; 17(2):333-6. PubMed ID: 17895
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of Fluoroimmunoassays for the determination of individual or combined levels of procainamide and N-acetylprocainamide in serum.
    Al-Hakiem MH; Smith DS; Landon J
    J Immunoassay; 1982; 3(1):91-110. PubMed ID: 6182162
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum drug concentrations in patients with ischemic heart disease after administration of a sustained release procainamide preparation.
    Zema MJ; Mirando T
    Angiology; 1983 Jan; 34(1):32-9. PubMed ID: 6186164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.